Found 6 matching trials
Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy
PHASE2The aim of this multicentre, prospective, double blind, placebo controlled,...
Location
Charité University Berlin
Clinical Trial of Green Tea Catechins in Men on Active Surveillance
PHASE2This randomized double-blinded Phase II clinical trial will evaluate the bi...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Sunphenon in Progressive Forms of Multiple Sclerosis
PHASE2The investigators hypothesize that an oral Sunphenon EGCg (Epigallocatechin...
Location
Charité Universitätsmedizin Berlin (NeuroCure Clinical Research Center)
Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease
PHASE2EGCG has shown a neuroprotective effect in cell-experimental and animal stu...
Location
Charite University Medicine Berlin
Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
PHASE3MSA is a rapidly progressive disorder with an average survival time of abou...
Location
Neurology Department, Ludwig-Maximilians University
Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)
PHASE1Hypothesis:
Sunphenon, a green tea extract containing 95% egcg, given dail...
Location
NeuroCure Clinical Research Center, Charite University, Berlin